The effect of salbutamol administration by inhalation together with rapid and deep breathing in comparison with the standard method: A clinical trial
Phase 3
- Conditions
- DYSPNEA.Upper respiratory tract hypersensitivity reaction, site unspecified
- Registration Number
- IRCT20171231038154N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Patients 15–75 years of age who visit the emergency department of Shahid Sadoughi Hospital in Yazd, Iran, due to bronchospasm caused by inhalation, asthma, or COPD. Lack of severe respiratory distress and absence of other underlying diseases that require treatments other than inhaled salbutamol.
Exclusion Criteria
Patients who need treatments other than salbutamol, such as atrovent, combivent, or pulmicort;
Patients who visit the emergency department with signs of respiratory failure, including acrocyanosis, PO2 below 60 mmHg, or PCO2 above 80 mmHg
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Peak expiratory flow. Timepoint: 0, 5min, 10min, 15min. Method of measurement: peak flow meter.
- Secondary Outcome Measures
Name Time Method